![]() |
|
|
Vol. 288, Issue 1, 1-5, January 1999
"Bernard B. Brodie" Department of Neuroscience, Neurotoxicology
Unit, University of Cagliari, Cagliari, Italy
Dithiocarbamate compounds are widely used agricultural
fungicides that display low acute toxicity in mammals and that may become neurotoxic after prolonged exposure. Mancozeb, among other dithiocarbamates tested, proved to be the most potent
(Ki= 0.27 µM) at noncompetitively
inhibiting the in vitro ATP-dependent uptake of
[3H]glutamate in rat cortical vesicles.
Furthermore, mancozeb partially (20%) inhibited the ATP-dependent
uptake of [14C]methylamine, used as an index for
the vesicular transmembrane proton gradient (
pH), and evoked its
efflux from organelles previously incubated with the
3H-labeled marker. Meanwhile, the vesicular uptake of
36chloride
anions whose concentrations
regulate the transmembrane potential gradient (
SV)
was not impaired. The dithiocarbamate effects on the vesicular
transport of [3H]glutamate thus appeared to involve
mainly the
pH gradient rather than the potential gradient.
Dithiocarbamate metabolites, the potent neurotoxin carbon disulfide
included, did not affect the uptake process, thus implying the
relevance for inhibition of the persistence, if any, of parent
compounds in the brain. The present novel and potent in vitro
interferences of selected dithiocarbamate pesticides with the vesicular
transport of glutamate, if representative of in vivo alterations, may
play some role in the probably complex origin of dithiocarbamate neurotoxicity.
This article has been cited by other articles:
![]() |
M. Tsang and L. Trombetta The protective role of chelators and antioxidants on mancozeb-induced toxicity in rat hippocampal astrocytes Toxicology and Industrial Health, September 1, 2007; 23(8): 459 - 470. [Abstract] [PDF] |
||||
![]() |
M. Thiruchelvam, E. K. Richfield, R. B. Baggs, A. W. Tank, and D. A. Cory-Slechta The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease J. Neurosci., December 15, 2000; 20(24): 9207 - 9214. [Abstract] [Full Text] [PDF] |
||||